Drug: diprivan Quarter: 2016Q3
Total Drug/Injury Combinations: 40 Number of Pages: 2
DRUGNAME | PT | EventCount | |
---|---|---|---|
DIPRIVAN | Oedema peripheral | 2 | view events |
DIPRIVAN | Retroperitoneal lymphadenopathy | 2 | view events |
DIPRIVAN | Tachycardia | 2 | view events |
DIPRIVAN | Therapeutic response decreased | 2 | view events |
DIPRIVAN | Urticaria | 2 | view events |
DIPRIVAN | Venous occlusion | 2 | view events |
DIPRIVAN | Venous thrombosis | 2 | view events |
DIPRIVAN | Anaphylactic shock | 1 | view events |
DIPRIVAN | Anxiety | 1 | view events |
DIPRIVAN | Death | 1 | view events |
DIPRIVAN | Drug level above therapeutic | 1 | view events |
DIPRIVAN | Dystonia | 1 | view events |
DIPRIVAN | Extravasation | 1 | view events |
DIPRIVAN | Gamma-glutamyltransferase increased | 1 | view events |
DIPRIVAN | Hepatocellular injury | 1 | view events |
DIPRIVAN | Intentional product misuse | 1 | view events |
DIPRIVAN | Musculoskeletal stiffness | 1 | view events |
DIPRIVAN | Product quality issue | 1 | view events |
DIPRIVAN | Shock | 1 | view events |
DIPRIVAN | Transaminases increased | 1 | view events |
Total Drug/Injury Combinations: 40 Number of Pages: 2
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)